Production of Inactivated Influenza H5N1 Vaccines from MDCK Cells in Serum-Free Medium

Abstract

The advantages of this SF cell-based manufacturing process could reduce the animal serum contamination, the cost and lot-to-lot variation of SC medium production. This study provides useful information to manufacturers that are planning to use SF medium for cell-based influenza vaccine production.